As of 2025-07-04, the EV/EBITDA ratio of RegeneRx Biopharmaceuticals Inc (RGRX) is -0.98. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. RGRX's latest enterprise value is 1.33 mil USD. RGRX's TTM EBITDA according to its financial statements is -1.36 mil USD. Dividing these 2 quantities gives us the above RGRX EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | - | - |
| Forward P/E multiples | - | - |
| Fair Price | - | - |
| Upside | - | - |
| Date | EV/EBITDA |
| 2025-04-30 | -0.98 |
| 2025-04-25 | -0.98 |
| 2025-04-23 | -0.98 |
| 2025-04-16 | -0.98 |
| 2025-04-15 | -0.98 |
| 2025-04-14 | -0.98 |
| 2025-04-11 | -0.98 |
| 2025-04-04 | -0.98 |
| 2025-03-31 | -0.98 |
| 2025-03-24 | -0.98 |
| 2025-03-07 | -0.98 |